Fifteen years of experience with intramuscular testosterone undecanoate for substitutio... - 0 views
-
Nathan Goodyear on 13 Mar 14Abstract presented finds that Testosterone IM undecanoate significantly reduced metabolic syndrome parameters in men. This study looked at men with secondary hypogonadism and late onset. The ages were from 15-72. The full is not available as of this post. The study only looked at serum T. This limits the usefulness of this test. According to this abstract, no evaluation of SHBG was performed. Though not significant, PSA and prostate volume increased.